Early in the Covid pandemic, Adrian Hill, head of Oxford university’s Jenner Institute, needed to find a company to roll out his group’s vaccine. There was a condition: the partner had to charge little in low- and middle-income countries, so that the vaccine wouldn’t be limited to the rich. “If there’s one thing that drives many of us here, the word is inequity,” says Hill, a slight, fast-talking 63-year-old.
在新冠肺炎疫情的早期，牛津大學詹納研究所所長阿德里安·希爾(Adrian Hill)需要找到一家公司來推廣他的團隊的疫苗。有一個條件：合作伙伴必須在低收入和中等收入國家收取很少的費用，這樣疫苗就不會局限于富人。“如果有一件事驅使我們來到這里，那就是不平等，”希爾說，他今年63歲，身材瘦小，說話語速很快。
您已閱讀4%（565字），剩余96%（12996字）包含更多重要信息，訂閱以繼續探索完整內容，并享受更多專屬服務。